ASCO22: research links race, ethnicity and poverty with lower OS in children with high-risk neuroblastoma

The 5-year overall survival (OS) rate for children with high-risk neuroblastoma varied by race, ethnicity and poverty according to a study presented at the Annual Society of Clinical Oncology (ASCO) Meeting 2022 (3–7 June, IL, USA). This study looked at treatment outcomes data of 696 children with high-risk neuroblastoma from three different clinical trials by Children's Oncology Group (COG). The investigators assessed OS and event-free survival (EFS) from time of trial enrolment. The study included children who were Black non-Hispanic (16%), Hispanic (11%), other non-Hispanic (4%) and white non-Hispanic (69%). In addition, one-third had public insurance only (which was used...